Neuromyelitis Optica Pathology in Rats Following Intraperitoneal Injection of NMO-IgG and Intracerebral Needle Injury

Overview

Journal Acta Neuropathol Commun

Publisher Biomed Central

Specialty Neurology

Date 2014 Apr 25

PMID 24758159

Citations 29

Authors

Nithi Asavapanumas

A S Verkman

Affiliations

Soon will be listed here.

Abstract

Introduction: Animal models of neuromyelitis optica (NMO) are needed for drug testing and evaluation of NMO disease pathogenesis mechanisms.

Results: We describe a novel passive-transfer model of NMO in which rats made seropositive for human anti-aquaporin-4 (AQP4) immunoglobulin G antibody (NMO-IgG) by intraperitoneal (IP) injections were subject to intracerebral needle injury. Following a single IP injection, NMO-IgG distributed rapidly to peripheral AQP4-expressing cells (kidney collecting duct, gastric glands, airways, skeletal muscle) and area postrema in brain, but not elsewhere in the central nervous system; however, no pathology was seen in brain, spinal cord, optic nerve or peripheral tissues. After testing various maneuvers to produce NMO-IgG-dependent pathology in brain, we found that transient puncture of brain parenchyma with a 28-gauge needle in NMO-IgG seropositive rats produced robust NMO pathology around the needle track, with loss of AQP4 and glial fibrillary acidic protein, granulocyte and macrophage infiltration, centrovascular deposition of activated complement, and blood-brain barrier disruption, with demyelination by 5 days. Pathology was not seen in rats receiving control (non-NMO) human IgG or in NMO-IgG-seropositive rats made complement-deficient by cobra venom factor. Interestingly, at 1 day a reversible, multifocal astrocytopathy was seen with loss of AQP4 and GFAP (but not myelin) in areas away from the needle track.

Conclusions: NMO-IgG-seropositivity alone is not sufficient to cause NMO pathology in rats, but a single intracerebral needle insertion, without pre-existing inflammation or infusion of pro-inflammatory factors, was sufficient to produce robust NMO pathology in seropositive rats.

Citing Articles

Scientific issues with rodent models of neuromyelitis optic spectrum disorders.

Huang Y, Wang T, Wang F, Wu Y, Ai J, Zhang Y Front Immunol. 2024; 15:1423107.

PMID: 39628487 PMC: 11611858. DOI: 10.3389/fimmu.2024.1423107.

Association between TIMP1 polymorphism and female neuromyelitis optica spectrum disorder in Chinese population.

Yan H, Wang Y, Guo R, Jia Z, Liu J, Li B Heliyon. 2024; 10(17):e37091.

PMID: 39296182 PMC: 11409102. DOI: 10.1016/j.heliyon.2024.e37091.

Structural basis for antibody-mediated NMDA receptor clustering and endocytosis in autoimmune encephalitis.

Wang H, Xie C, Deng B, Ding J, Li N, Kou Z Nat Struct Mol Biol. 2024; 31(12):1987-1996.

PMID: 39227720 PMC: 11638077. DOI: 10.1038/s41594-024-01387-3.

Humanized-Aquaporin-4-Expressing Rat Created by Gene-Editing Technology and Its Use to Clarify the Pathology of Neuromyelitis Optica Spectrum Disorder.

Namatame C, Abe Y, Miyasaka Y, Takai Y, Matsumoto Y, Takahashi T Int J Mol Sci. 2024; 25(15).

PMID: 39125739 PMC: 11311328. DOI: 10.3390/ijms25158169.

Combined platelet-to-lymphocyte ratio and blood-brain barrier biomarkers as indicators of disability in acute neuromyelitis optica spectrum disorder.

Yan H, Wang Y, Li Y, Shen X, Ma L, Wang M Neurol Sci. 2023; 45(2):709-718.

PMID: 37676374 DOI: 10.1007/s10072-023-07058-3.

References

Bergman I, Basse P, Barmada M, Griffin J, Cheung N . Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors. Cancer Immunol Immunother. 2000; 49(4-5):259-66. PMC: 11036976. DOI: 10.1007/s002620000120. View

Ratelade J, Zhang H, Saadoun S, Bennett J, Papadopoulos M, Verkman A . Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss. Acta Neuropathol. 2012; 123(6):861-72. PMC: 3581313. DOI: 10.1007/s00401-012-0986-4. View

Bennett J, Lam C, Kalluri S, Saikali P, Bautista K, Dupree C . Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol. 2009; 66(5):617-29. PMC: 3180961. DOI: 10.1002/ana.21802. View

Kira J . Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders. J Neurol Sci. 2011; 311(1-2):69-77. DOI: 10.1016/j.jns.2011.08.043. View

Singhrao S, Neal J, Rushmere N, Morgan B, Gasque P . Differential expression of individual complement regulators in the brain and choroid plexus. Lab Invest. 1999; 79(10):1247-59. View

Frigeri A, Gropper M, Umenishi F, Kawashima M, Brown D, Verkman A . Localization of MIWC and GLIP water channel homologs in neuromuscular, epithelial and glandular tissues. J Cell Sci. 1995; 108 ( Pt 9):2993-3002. DOI: 10.1242/jcs.108.9.2993. View

Pittock S, Lennon V, McKeon A, Mandrekar J, Weinshenker B, Lucchinetti C . Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol. 2013; 12(6):554-62. DOI: 10.1016/S1474-4422(13)70076-0. View

Tradtrantip L, Ratelade J, Zhang H, Verkman A . Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody. Ann Neurol. 2012; 73(1):77-85. PMC: 3567850. DOI: 10.1002/ana.23741. View

Pohl M, Kawakami N, Kitic M, Bauer J, Martins R, Fischer M . T cell-activation in neuromyelitis optica lesions plays a role in their formation. Acta Neuropathol Commun. 2013; 1:85. PMC: 3879999. DOI: 10.1186/2051-5960-1-85. View

10.

van Beek J, van Meurs M, t Hart B, Brok H, Neal J, Chatagner A . Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation. J Immunol. 2005; 174(4):2353-65. DOI: 10.4049/jimmunol.174.4.2353. View

11.

Zhang H, Verkman A . Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. J Autoimmun. 2014; 53:67-77. PMC: 4162764. DOI: 10.1016/j.jaut.2014.02.011. View

12.

Gelderman K, Zijlmans H, Vonk M, Gorter A . CD55 expression patterns on intestinal neuronal tissue are divergent from the brain. Gut. 2004; 53(4):507-13. PMC: 1773999. DOI: 10.1136/gut.2003.026773. View

13.

Tradtrantip L, Asavapanumas N, Verkman A . Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase. Mol Pharmacol. 2013; 83(6):1268-75. PMC: 3657102. DOI: 10.1124/mol.113.086470. View

14.

Saadoun S, Waters P, MacDonald C, Bell B, Vincent A, Verkman A . Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain. Ann Neurol. 2012; 71(3):323-33. PMC: 3643520. DOI: 10.1002/ana.22686. View

15.

Kitic M, Hochmeister S, Wimmer I, Bauer J, Misu T, Mader S . Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats. Acta Neuropathol Commun. 2013; 1:5. PMC: 3776214. DOI: 10.1186/2051-5960-1-5. View

16.

Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T . Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. Biochem Biophys Res Commun. 2010; 394(1):205-10. DOI: 10.1016/j.bbrc.2010.02.157. View

17.

Phuan P, Zhang H, Asavapanumas N, Leviten M, Rosenthal A, Tradtrantip L . C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta Neuropathol. 2013; 125(6):829-40. PMC: 3941651. DOI: 10.1007/s00401-013-1128-3. View

18.

Ratelade J, Asavapanumas N, Ritchie A, Wemlinger S, Bennett J, Verkman A . Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica. Acta Neuropathol. 2013; 126(5):699-709. PMC: 3890328. DOI: 10.1007/s00401-013-1172-z. View

19.

Saadoun S, Waters P, Bell B, Vincent A, Verkman A, Papadopoulos M . Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain. 2010; 133(Pt 2):349-61. PMC: 2822632. DOI: 10.1093/brain/awp309. View

20.

Papadopoulos M, Verkman A . Aquaporin water channels in the nervous system. Nat Rev Neurosci. 2013; 14(4):265-77. PMC: 3732112. DOI: 10.1038/nrn3468. View